Expanded Access Protocol Thymus Transplantation

NCT02274662 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Poor Thymic Function
Immunodeficiency
Athymia
Immunoreconstitution
Thymus Transplantation
Low T Cell Numbers

Interventions

BIOLOGICAL: Cultured Thymus Tissue
PROCEDURE: Blood Draw
DRUG: Rabbit Anti-Thymocyte Globulin and Cyclosporine or Tacrolimus

Sponsor

Sumitomo Pharma Switzerland GmbH